Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Stussi G, Halter J, Tichelli A, Meyer-Monard S, Buser AS, Arber C, Heim D, Passweg JR, Rischewski J, Paulussen M, Gratwohl A. Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies. Bone Marrow Transplant 2009;45:103-9. [DOI: 10.1038/bmt.2009.123] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]

For:	Stussi G, Halter J, Tichelli A, Meyer-Monard S, Buser AS, Arber C, Heim D, Passweg JR, Rischewski J, Paulussen M, Gratwohl A. Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies. Bone Marrow Transplant 2009;45:103-9. [DOI: 10.1038/bmt.2009.123] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]

Number	Cited by Other Article(s)
1	O'Meara A, Pabst T, Heim D, Gerull S, Bucher C, Halter J, Arber C, Rovò A, Tichelli A, Gratwohl A, Stern M. High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML. Bone Marrow Transplant 2010;46:636-40. [PMID: 20697364 DOI: 10.1038/bmt.2010.181] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
2	Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. Bone Marrow Transplant 2010;46:344-9. [DOI: 10.1038/bmt.2010.137] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
3	Winkler J, Rech D, Kallert S, Rech J, Meidenbauer N, Roesler W, Mackensen A. Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: a case report. Leuk Res 2010;34:e270-2. [PMID: 20627386 DOI: 10.1016/j.leukres.2010.04.011] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2010] [Revised: 03/31/2010] [Accepted: 04/13/2010] [Indexed: 12/01/2022] Abstract Collapse Key Words Collapse MESH Headings Adult Antineoplastic Agents/therapeutic use Benzenesulfonates Female Graft vs Host Disease Hematopoietic Stem Cell Transplantation/adverse effects Humans Leukemia, Myeloid, Acute/drug therapy Leukemia, Myeloid, Acute/genetics Leukemia, Myeloid, Acute/metabolism Niacinamide/analogs & derivatives Phenylurea Compounds Point Mutation Protein Kinase Inhibitors/therapeutic use Pyridines Recurrence Sorafenib Transplantation, Homologous fms-Like Tyrosine Kinase 3/antagonists & inhibitors fms-Like Tyrosine Kinase 3/genetics Collapse Grants Collapse Affiliation(s) Collapse